Market Overview:
The global POC infectious diseases market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, growing demand for point-of-care diagnostics, and technological advancements in POC diagnostics. The flu segment is expected to account for the largest share of the global POC infectious diseases market in 2018. This segment is projected to grow at a CAGR of 7.8% from 2018 to 2030. The adenovirus segment is projected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increasing incidence of adenovirus infections worldwide and rising demand for rapid diagnosis and treatment options for these infections. In terms of application, hospitals & clinics are expected to account for the largest share of the global POC infectious diseases market in 2018 followed by clinical diagnostic laboratories.
Product Definition:
POC infectious diseases refers to infections that can be diagnosed through a simple blood or other specimen test done in a doctor's office or clinic. These infections are typically caused by bacteria, viruses, or parasites and can be treated with antibiotics, antivirals, or antiparasitics. POC infectious diseases are important because they can often be treated quickly and easily without the need for expensive and time-consuming lab tests.
Flu:
The global Flu market size was valued at USD 8.1 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period.
Adenovirus:
Adenovirus is a virus that infects the cells of the respiratory system and causes colds. The common symptoms associated with adenovirus infections are cough, fever, sore throat, runny nose and body ache. Adenoviruses are also responsible for causing hand-foot-mouth disease (HFMD) in children.
Application Insights:
The clinical diagnostic laboratories segment dominated the global POC infectious diseases market in 2017. This can be attributed to factors such as an increase in incidence of chronic infectious diseases and rising demand for rapid, accurate, and sensitive tests for diagnosis. For instance, according to the U.S. Department of Health & Human Services (HHS), around 2 million people are diagnosed with tuberculosis every year globally and about 1 million deaths occur due to this disease worldwide also known as X-ray resistant TB which requires highly sensitive testing procedures for detection. Therefore, a growing number of hospitals & clinics coupled with a high prevalence rate is expected to drive segment growth during the forecast period (18 to 28) years from 2018 to 2030 globally owing to increasing incidences of hospital-acquired infections along with other communicable diseases that require medical attention at hospitals or clinics such as chickenpox, typhoid fever etc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high R&D investment by them and their continuous efforts for commercialization of novel diagnostic products at an affordable price. The U.S., which is one of the most developed countries in terms of healthcare infrastructure, witnessed a higher rate of POC infections as compared to other regions during pandemic COVID-19.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to factors such as increasing prevalence rates for infectious diseases such as TB and malaria; rising incidences associated with cancer; growing immunization initiatives against these diseases coupled with government support & funding are some others that will drive this regional market forward during future years (8).
Growth Factors:
- Increasing incidence of infectious diseases: The incidence of infectious diseases is increasing at a rapid pace across the globe. This is primarily owing to the changing lifestyle and environmental conditions. This, in turn, is propelling the demand for point-of-care diagnostics for infectious diseases.
- Rising awareness about POC diagnostics: There is a growing awareness among people about the benefits of POC diagnostics over traditional laboratory tests. This is aiding in the growth of the market for POC infectious diseases diagnostics globally.
- Technological advancements: The technological advancements in POC diagnostic devices are helping to improve their accuracy and speed of diagnosis significantly. This is boosting their adoption rates across clinics and hospitals worldwide thereby driving market growth."
Scope Of The Report
Report Attributes
Report Details
Report Title
POC Infectious Diseases Market Research Report
By Type
Flu, Adenovirus, Malaria, Streptococcal Bacteremia, Tuberculosis (TB), Occult Blood, HIV
By Application
Hospital& Clinics, Clinical Diagnostic Laboratories, Homecare Settings
By Companies
Abbott, Meridian Bioscience, Orasure Technologies, Trinity Biotech, Beckman Coulter/ Danaher, Becton Dickinson, Biomerieux, Bio-Rad, Cepheid, Diamedix, Diasorin, Eiken Chemical, Enzo Biochem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
135
Number of Tables & Figures
95
Customization Available
Yes, the report can be customized as per your need.
Global POC Infectious Diseases Market Report Segments:
The global POC Infectious Diseases market is segmented on the basis of:
Types
Flu, Adenovirus, Malaria, Streptococcal Bacteremia, Tuberculosis (TB), Occult Blood, HIV
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital& Clinics, Clinical Diagnostic Laboratories, Homecare Settings
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Meridian Bioscience
- Orasure Technologies
- Trinity Biotech
- Beckman Coulter/ Danaher
- Becton Dickinson
- Biomerieux
- Bio-Rad
- Cepheid
- Diamedix
- Diasorin
- Eiken Chemical
- Enzo Biochem
Highlights of The POC Infectious Diseases Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Flu
- Adenovirus
- Malaria
- Streptococcal Bacteremia
- Tuberculosis (TB)
- Occult Blood
- HIV
- By Application:
- Hospital& Clinics
- Clinical Diagnostic Laboratories
- Homecare Settings
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the POC Infectious Diseases Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
POC infectious diseases are those that primarily affect people of color. This includes both minority and indigenous populations, as well as people from immigrant backgrounds. These diseases can be difficult to diagnose and treat, which is why it's important for health care providers to be aware of them.
Some of the major players in the poc infectious diseases market are Abbott, Meridian Bioscience, Orasure Technologies, Trinity Biotech, Beckman Coulter/ Danaher, Becton Dickinson, Biomerieux, Bio-Rad, Cepheid, Diamedix, Diasorin, Eiken Chemical, Enzo Biochem.
The poc infectious diseases market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 POC Infectious Diseases Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 POC Infectious Diseases Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 POC Infectious Diseases Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the POC Infectious Diseases Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global POC Infectious Diseases Market Size & Forecast, 2018-2028
4.5.1 POC Infectious Diseases Market Size and Y-o-Y Growth
4.5.2 POC Infectious Diseases Market Absolute $ Opportunity
Chapter 5 Global POC Infectious Diseases Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 POC Infectious Diseases Market Size Forecast by Type
5.2.1 Flu
5.2.2 Adenovirus
5.2.3 Malaria
5.2.4 Streptococcal Bacteremia
5.2.5 Tuberculosis (TB)
5.2.6 Occult Blood
5.2.7 HIV
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global POC Infectious Diseases Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 POC Infectious Diseases Market Size Forecast by Applications
6.2.1 Hospital& Clinics
6.2.2 Clinical Diagnostic Laboratories
6.2.3 Homecare Settings
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global POC Infectious Diseases Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 POC Infectious Diseases Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America POC Infectious Diseases Analysis and Forecast
9.1 Introduction
9.2 North America POC Infectious Diseases Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America POC Infectious Diseases Market Size Forecast by Type
9.6.1 Flu
9.6.2 Adenovirus
9.6.3 Malaria
9.6.4 Streptococcal Bacteremia
9.6.5 Tuberculosis (TB)
9.6.6 Occult Blood
9.6.7 HIV
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America POC Infectious Diseases Market Size Forecast by Applications
9.10.1 Hospital& Clinics
9.10.2 Clinical Diagnostic Laboratories
9.10.3 Homecare Settings
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe POC Infectious Diseases Analysis and Forecast
10.1 Introduction
10.2 Europe POC Infectious Diseases Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe POC Infectious Diseases Market Size Forecast by Type
10.6.1 Flu
10.6.2 Adenovirus
10.6.3 Malaria
10.6.4 Streptococcal Bacteremia
10.6.5 Tuberculosis (TB)
10.6.6 Occult Blood
10.6.7 HIV
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe POC Infectious Diseases Market Size Forecast by Applications
10.10.1 Hospital& Clinics
10.10.2 Clinical Diagnostic Laboratories
10.10.3 Homecare Settings
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific POC Infectious Diseases Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific POC Infectious Diseases Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific POC Infectious Diseases Market Size Forecast by Type
11.6.1 Flu
11.6.2 Adenovirus
11.6.3 Malaria
11.6.4 Streptococcal Bacteremia
11.6.5 Tuberculosis (TB)
11.6.6 Occult Blood
11.6.7 HIV
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific POC Infectious Diseases Market Size Forecast by Applications
11.10.1 Hospital& Clinics
11.10.2 Clinical Diagnostic Laboratories
11.10.3 Homecare Settings
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America POC Infectious Diseases Analysis and Forecast
12.1 Introduction
12.2 Latin America POC Infectious Diseases Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America POC Infectious Diseases Market Size Forecast by Type
12.6.1 Flu
12.6.2 Adenovirus
12.6.3 Malaria
12.6.4 Streptococcal Bacteremia
12.6.5 Tuberculosis (TB)
12.6.6 Occult Blood
12.6.7 HIV
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America POC Infectious Diseases Market Size Forecast by Applications
12.10.1 Hospital& Clinics
12.10.2 Clinical Diagnostic Laboratories
12.10.3 Homecare Settings
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) POC Infectious Diseases Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) POC Infectious Diseases Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) POC Infectious Diseases Market Size Forecast by Type
13.6.1 Flu
13.6.2 Adenovirus
13.6.3 Malaria
13.6.4 Streptococcal Bacteremia
13.6.5 Tuberculosis (TB)
13.6.6 Occult Blood
13.6.7 HIV
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) POC Infectious Diseases Market Size Forecast by Applications
13.10.1 Hospital& Clinics
13.10.2 Clinical Diagnostic Laboratories
13.10.3 Homecare Settings
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 POC Infectious Diseases Market: Competitive Dashboard
14.2 Global POC Infectious Diseases Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Meridian Bioscience
14.3.3 Orasure Technologies
14.3.4 Trinity Biotech
14.3.5 Beckman Coulter/ Danaher
14.3.6 Becton Dickinson
14.3.7 Biomerieux
14.3.8 Bio-Rad
14.3.9 Cepheid
14.3.10 Diamedix
14.3.11 Diasorin
14.3.12 Eiken Chemical
14.3.13 Enzo Biochem
